Marketing that understands the science and the sector
Read Marketing works exclusively with early-stage biotech, medtech and medical device companies spinning out of universities across the North East of England and Scotland.
We know the ecosystem, the investors, the NHS pathways and how to translate world-class research into commercial traction.
Not a generalist agency. A sector specialist.
Working with spin-outs and early-stage companies from pre-seed through to Series A and beyond across biotech, medtech, medical devices and digital health.
Most marketing agencies understand start-ups. Very few understand the difference between what you say to an NHS commissioner and what you say to a venture investor or why the language that works in a grant application fails completely on an exhibition stand.
Whether you’re three months out of the lab or preparing your Series A raise, we bring the strategic clarity and execution capability that early-stage companies need without the overhead of a full-service agency.
Read Marketing was built for exactly this intersection. We combine deep life sciences sector knowledge with an intimate understanding of the commercial landscape in the North East of England and Scotland two regions producing world-class biotech and medtech innovation that are consistently underserved by agencies defaulting to London-centric playbooks.
Six capabilities – All built for life sciences.
Conference & Events Strategy
From BioTrinity to the Scottish Life Sciences Association annual conference, Arab Health to the Northeast England Life Sciences Conference we build a targeted 12-month events programme around your stage and objectives, then help you execute it properly: stand design, delegate briefings, speaking submissions, and structured follow-up systems.
#EventSelection #StandStrategy #SpeakingSlots #InvestorMeetings #FollowupSystems
Brand Strategy & Positioning
Your academic reputation is your greatest asset and your biggest communication risk. We translate complex science into investor-grade narratives clearly articulating the unmet need, the clinical or commercial validation, and the team behind the technology. Built for companies where the brand IS the founding scientists.
#SpinoutPositioning #InvestorNarrative #VisualIdentity #MessagingHierarchy
Digital & Content Marketing
Life sciences audiences require evidence, not enthusiasm. We build content programmes that demonstrate scientific credibility, clinical data summaries, regulatory milestone communications, white papers for NHS procurement audiences, distributed across the channels where your investors, customers and partners actually spend time.
#LinkedInStrategy #Website #WhitePapers #ClinicalComms #EmailCampaigns
PR & Media Relations
Coverage in The Manufacturer, MDDUS, PMLiVE, Digital Health News or MedCity News lands differently than a press release in a local business journal. We know the trade journalists, the editors and the sector-specific platforms that give early-stage life sciences companies the credibility that generic PR cannot deliver.
#TradeMedia #FundingAnnouncements #ClinicalMilestones #RegionalPress
NHS & Healthcare Market Access
The NHS procurement pathway is unlike any other B2B sales process. We help medtech and digital health companies position their products within the AHSN network, ICS innovation programmes, and NHS Supply Chain with messaging tailored to commissioners, clinical leads and procurement teams rather than general technology buyers.
#AHSNPositioning #ICSEngagement #ClinicalEvidenceComms #NHSSupplyChain
Investor & Stakeholder Communications
Fundraising is a long game. We build the visibility and credibility that makes the conversation easier, positioning your founders as thought leaders in the sector, keeping your existing investors informed with regular milestone communications, and preparing the narrative for your next round well before you need to tell it.
#PitchNarrative #InvestorUpdates #ThoughtLeadership #SeriesAPrep
Marketing that fits your stage, not a template
The marketing needs of a pre-seed spin-out are fundamentally different from a Series A company building a commercial pipeline. We scope every engagement around your stage.
| 01 – Diagnostic session A single focused call to understand your stage, your IP, your target audience and what commercial conversations are already in motion. No briefing documents, no questionnaires. | 02 – Strategy sprint Within two weeks we deliver a written strategy positioning, priority channels, 12-month activity plan that reflects your stage, your funding timeline, and the specific landscape of the North East or Scottish ecosystem. |
| 03 – Execution We work as an embedded partner, not an agency managing from a distance. Conference prep, content creation, investor comms, PR delivered with the same attention to the science as to the marketing. | 04 – Review & adapt Quarterly reviews aligned to your funding milestones. As your stage changes new data, new round, new commercial conversations the strategy evolves with it. Not a retainer that runs on autopilot. |
Let’s talk about your stage
Whether you’re three months post-spin-out or preparing a Series A raise, the conversation starts with understanding where you are. No pitch, no obligations just a focused call about your company, your market, and what marketing can do for you right now.
read-marketing.com 